Value
4.8/10data confidence 33%| Component | Sub-score |
|---|---|
| P/S | 6.1 |
| Analyst target | 4.0 |
SGHT · Why this verdict
Why Sight Sciences (SGHT) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.1/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Sight Sciences is a cash-burning, high-beta medical device name that has traded 8.0% above its analyst target, with a 3-of-4 earnings beat streak but weak quality and insider selling.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The stock trades above the analyst target (-8.0% upside), so the target has been reached and the reward-to-risk is negative at -0.68. Bear case | Upside to the analyst target should turn positive through a pullback or higher targets. | ↑Improving |
| CounterAnalyst targets lag a stock with a 3/4 earnings beat streak, and revisions after the next report could lift the target. | ||
Quality scores 3.4, below the 4.0 floor, with free cash flow at -10% of revenue and a Rule of 40 score of 9, which fails. Quality breakdown | Quality score should rise above 4.0 as free cash flow approaches breakeven. | →Stable |
| CounterA burn of only 10% of revenue is modest, and improving losses per share suggest the trajectory is positive. | ||
The company beat estimates in 3 of the last 4 quarters, with an average surprise of 26.6%, and the next report is on 2026-11-05. Earnings | EPS should meet or beat estimates at the 2026-11-05 report. | ↓Deteriorating |
| CounterThe beats are on small negative loss figures, and the most recent May quarter was a miss, so the streak is fragile. | ||
Insiders sold $652,777 (0.133% of market cap) across 5 sales in 90 days with no buying, and implied volatility is 203%. Insider breakdown | Net insider selling should stop and implied volatility should fall below 120%. | →Stable |
| CounterThe selling is minor in size and often routine, while the high implied volatility reflects the upcoming earnings date. | ||
Momentum scores 4.1, below the 4.5 threshold, with falling on-balance volume in a range-bound setup at RSI 56. Momentum breakdown | Momentum should rise above 4.5 with rising volume and a break from the range. | ↑Improving |
| CounterPrice is above the 200-day moving average, so the trend is intact despite weak momentum readings. | ||
The stock trades above the analyst target (-8.0% upside), so the target has been reached and the reward-to-risk is negative at -0.68.
↑ImprovingBear case
- Expectation
- Upside to the analyst target should turn positive through a pullback or higher targets.
CounterAnalyst targets lag a stock with a 3/4 earnings beat streak, and revisions after the next report could lift the target.
Quality scores 3.4, below the 4.0 floor, with free cash flow at -10% of revenue and a Rule of 40 score of 9, which fails.
→StableQuality breakdown
- Expectation
- Quality score should rise above 4.0 as free cash flow approaches breakeven.
CounterA burn of only 10% of revenue is modest, and improving losses per share suggest the trajectory is positive.
The company beat estimates in 3 of the last 4 quarters, with an average surprise of 26.6%, and the next report is on 2026-11-05.
↓DeterioratingEarnings
- Expectation
- EPS should meet or beat estimates at the 2026-11-05 report.
CounterThe beats are on small negative loss figures, and the most recent May quarter was a miss, so the streak is fragile.
Insiders sold $652,777 (0.133% of market cap) across 5 sales in 90 days with no buying, and implied volatility is 203%.
→StableInsider breakdown
- Expectation
- Net insider selling should stop and implied volatility should fall below 120%.
CounterThe selling is minor in size and often routine, while the high implied volatility reflects the upcoming earnings date.
Momentum scores 4.1, below the 4.5 threshold, with falling on-balance volume in a range-bound setup at RSI 56.
↑ImprovingMomentum breakdown
- Expectation
- Momentum should rise above 4.5 with rising volume and a break from the range.
CounterPrice is above the 200-day moving average, so the trend is intact despite weak momentum readings.
Per-dimension breakdown
Quality
3.4/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 0.0 |
| Gross margin | 10.0 |
| Op margin | 0.0 |
| Net margin | 0.0 |
| Current ratio | 8.1 |
| FCF quality | 0.0 |
| Moat | 6.5 |
| Rule of 40 | 3.0 |
| Piotroski F | 6.7 |
- ▸Cash-burning: FCF -10% of revenue
- ▸Rule of 40: 9 (fail)
Growth
7.4/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 7.4 |
Momentum
7.1/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 5.0 |
| MACD | 7.3 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 4.1 |
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
6.1/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 6.6 |
| Price target | 6.5 |
| erm sentiment | 5.0 |
- ▸Light analyst coverage (6.0) — signal dampened
Insider
3.1/10data confidence 100%| Component | Sub-score |
|---|---|
| materiality | 3.0 |
| insider conviction | 2.0 |
| holder change | 4.6 |
| notable moves | 3.0 |
- ▸Notable insider selling — $652,777 (0.128% of mkt cap)
Peer rank
3.4/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 2.6 |
| quality rank | 1.0 |
| growth rank | 7.2 |
Technical
3.6/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 0.8 |
| support resistance | 1.1 |
| 52w position | 9.0 |
Risk (lower is worse)
4.4/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 8.5 |
| days to cover | 7.1 |
| volatility | 0.0 |
| put call | 8.9 |
| implied vol | 0.0 |
| max pain risk | 3.0 |
| beta | 1.8 |
| debt equity | 6.2 |
- ▸High IV: 240%
- ▸Above max pain $2
Catalyst
6.7/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
- ▸Strong earnings: 3B/1M
- ▸Earnings in 6 days
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCK:QUALITY_FLOORPassed (5)
- MOMENTUM:7.1>=5.5
- INSIDER:OK
- NEWS_EVENTS:NONE_RECENT
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
- ASYMMETRY:-0.3=NEGATIVE
- EARNINGS_PROXIMITY:6d<=7d
Warning (1)
- 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
-0.28
Upside
-4.3%
Downside
15.0%
Sizing output
AVOID
SetupBreakout — Golden cross, above all MAs, RSI 61, MACD bullish
EdgeNo clear edge — No clear edge identified
SuitabilityAggressive — Beta 2.45>1.3, MCap $0.5B<$5B
Investment implication
The SELL_IF_HOLDING verdict reflects the ASYMMETRY gate's -0.3=NEGATIVE outcome against Growth at 7.4 and asymmetric R:R of -0.28.
The strongest dimensions are Growth at 7.4, Momentum at 7.1, and Catalyst at 6.7; the weakest are Insider at 3.1, Peer rank at 3.4, and Quality at 3.4. The V9 engine flagged 2 failed gates with 1 warning, producing an asymmetric reward-to-risk of -0.28 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Price Above Analyst Target
Trip ifPrice stays more than 15% above the analyst target for 2 consecutive quarters.
- P2Quality Below Floor
Trip ifFree cash flow burn exceeds 25% of revenue for 2 consecutive quarters.
- P3Earnings Beat Streak
Trip ifEPS surprise stays below 0% for 2 consecutive quarters.
- P4Insider Selling Volatility
Trip ifNet insider selling exceeds 0.5% of market cap over a 90-day window.
- P5Weak Momentum Range Bound
Trip ifPrice falls below the $8.27 stop level while momentum stays below 4.5.